New nanopore DNA sequencing technology on a device the size of a USB stick could be used to diagnose infection – according to new research from the University of East Anglia and Public Health England.
Researchers tested the new technology with a complex problem – determining the cause of antibiotic resistance in a new multi-drug resistant strain of the bacterium that causes Typhoid.
The results, published today in the journal Nature Biotechnology, reveal that the small, accessible and cost effective technology could revolutionise genomic sequencing.
Current technology for ‘long read’ detailed genomic sequencing can be performed using expensive instrumentation (around £500,000). It is complex to perform, and generally only available in specialist laboratories.
The research team tested a new device called MinION, produced by Oxford Nanopore Technologies Ltd. The machine produces long sequencing reads using a different methodology that does not require optical imaging – but at a small fraction of the instrument cost (expected to be around £650 per device). These long reads are important when trying to determine where resistance genes are.
Researchers proved its utility by successfully mapping the multi-drug resistance genes in a strain called Salmonella Typhi haplotype H58 – which has recently emerged globally.
They successfully pinpointed the exact spot in the chromosomal structure that is home to the genes which makes it drug-resistant, known as an antibiotic resistance island. The MinION took just 18 hours to produce the results, with similar accuracy to current technologies.
Lead researcher Dr Justin O’Grady, from UEA’s Norwich Medical School, said: “This type of technology will revolutionise the way that we characterise the rapid spread of emerging antibiotic-resistant infectious diseases.
“This analysis would previously have taken months using traditional methods, due to extensive post-sequencing lab-based analysis. By the time the results are available, they might well be irrelevant for clinical diagnostics and guiding public health interventions.
“This is the first published research in the world to demonstrate the huge potential of MinION sequencing to solve important and complex biological problems.
“Public health and clinical laboratories could soon have easy access to this rapid, cheap technology which, in combination with short read sequencing, is capable of providing fully assembled bacterial genomes. Further improvements to the system are likely to remove the need for short read sequence data.
“MinION technology could potentially enable bacterial identification, diagnosis of infectious diseases and detection of drug-resistance at the point of clinical need.
“This type of technology makes next generation sequencing accessible to scientists everywhere.”
The Latest on: Nanopore DNA sequencing
via Google News
The Latest on: Nanopore DNA sequencing
- After 20 years, the human genome is (almost) complete — here’s what’s left to doon June 11, 2021 at 8:50 am
The newly updated sequence fills in most of the remaining gaps, providing the full 3.055 billion base pairs (“letters”) of our DNA code in its entirety.
- Resourceful solid-state nanopores: From blue energy production to big data processingon June 11, 2021 at 7:45 am
Jean-Pierre Leburton & Olgica Milenkovic, the University of Illinois at Urbana-Champaign, discuss how big data processing via bio-sensing ...
- The Human Genome Is—Finally!—Completeon June 11, 2021 at 5:00 am
The Human Genome Project left 8 percent of our DNA unexplored. Now, for the first time, those enigmatic regions have been revealed.
- Next-Generation Sequencing (NGS) Market Size 2021 Comprehensive Research Methodology, Regional Study and Business Operation Data Analysis by 2030on June 10, 2021 at 8:58 pm
In a recent published report, Kenneth Research has updated the market report for Next-Generation Sequencing (NGS) ...
- Chinese Gene Sequencing Firm Qitan Bags USD62.5 Million in New Funding Led by GL Ventures, CDHon June 7, 2021 at 11:45 pm
Qitan Technology, Chinese developer of nanopore-based fourth-generation DNA sequencing technology, has raised more than CNY400 million (USD62.5 million) in a Series-B funding round led by US ...
- New research in protein sequencing poised to transform medicineon June 7, 2021 at 9:27 am
While DNA provides the genetic recipe book for biological form and function, it is the job of the body's proteins to carry out the complex commands dictated by DNA's genetic code.
- Researchers may have sequenced the ‘final unknown’ of the human genomeon June 3, 2021 at 11:13 am
The claim, if confirmed, surpasses the achievement laid out by leaders from the Human Genome Project and Celera Genomics in 2000.
- Nanopore sequencing contradicts human genome integration of SARS-CoV-2on June 2, 2021 at 8:05 pm
Therefore, SARS-CoV-2 does not incorporate its genetic material into human genomic DNA during its ... using a sequencing technique called Oxford Nanopore Technologies (ONT) long-read sequencing.
- Nanopore Technology Market to Gain Impetus, Spurred by the Increasing Usage of DNA Sequencing Worldwideon June 1, 2021 at 10:09 pm
Quantapore Inc. is currently using nanopore technology to sequence vast amount of DNA. Several other companies are planning to invest in this technology, which in turn, is expected to encourage ...
via Bing News